Halozyme Therapeutics Inc (MEX:HALO)
MXN 1,327 (0%) Market Cap: 165.10 Bil Enterprise Value: 197.09 Bil PE Ratio: 28.59 PB Ratio: 42.89 GF Score: 87/100

Halozyme Therapeutics Inc at Leerink Global Healthcare Conference Transcript

Mar 10, 2026 / 05:00 PM GMT
Release Date Price: MXN1200


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

HALO.OQ - Halozyme Therapeutics Inc
Halozyme Therapeutics Inc at Leerink Global Healthcare Conference
Mar 10, 2026 / 05:00PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
So, thank you everybody for joining us today. It's very much my pleasure to, welcome Hale Lazyme to Larynx Global Health Care Conference. My name is Dave Reisinger, and, I'll be, having a conversation today with Helen Torley, the company's CEO. Congrats on all the progress in recent years. You've, been quite active with. Executing in the business and also executing on M&A to bring in new long-term growth drivers, so. I thought that we could just start off with asking you to provide some comments, including in particular on those two recent acquisitions of Electrify and Surf Bio, and then we'll take it from there.

--------------------------------------------------------------------------------
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot